EP0786013A1 - Method of monitoring endospore-forming bacteria - Google Patents
Method of monitoring endospore-forming bacteriaInfo
- Publication number
- EP0786013A1 EP0786013A1 EP95933543A EP95933543A EP0786013A1 EP 0786013 A1 EP0786013 A1 EP 0786013A1 EP 95933543 A EP95933543 A EP 95933543A EP 95933543 A EP95933543 A EP 95933543A EP 0786013 A1 EP0786013 A1 EP 0786013A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- coding region
- conserved regions
- endospore
- dna
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 241000894006 Bacteria Species 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims abstract description 24
- 238000012544 monitoring process Methods 0.000 title claims description 7
- 108091026890 Coding region Proteins 0.000 claims abstract description 23
- 108020004414 DNA Proteins 0.000 claims abstract description 17
- 230000004544 DNA amplification Effects 0.000 claims abstract description 6
- 230000003321 amplification Effects 0.000 claims abstract description 6
- 239000012634 fragment Substances 0.000 claims abstract description 6
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 29
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 5
- 101100366275 Bacillus subtilis (strain 168) spoIVB gene Proteins 0.000 claims description 2
- 238000011901 isothermal amplification Methods 0.000 claims description 2
- 238000012408 PCR amplification Methods 0.000 claims 1
- 108700026244 Open Reading Frames Proteins 0.000 abstract description 3
- 238000001514 detection method Methods 0.000 abstract 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 5
- 108091034117 Oligonucleotide Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 241000193469 Clostridium pasteurianum Species 0.000 description 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 241000304886 Bacilli Species 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 241001112696 Clostridia Species 0.000 description 2
- 241000193403 Clostridium Species 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 241000193462 [Clostridium] innocuum Species 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 241000193755 Bacillus cereus Species 0.000 description 1
- 241000193764 Brevibacillus brevis Species 0.000 description 1
- 241000193454 Clostridium beijerinckii Species 0.000 description 1
- 241000193155 Clostridium botulinum Species 0.000 description 1
- 241000193171 Clostridium butyricum Species 0.000 description 1
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- 108091029795 Intergenic region Proteins 0.000 description 1
- 241000193459 Moorella thermoacetica Species 0.000 description 1
- 108091092724 Noncoding DNA Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 210000004666 bacterial spore Anatomy 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
- 230000022912 endospore formation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
Definitions
- the present invention relates to a method of monitoring endospore-forming bacteria.
- Endospore-forming bacteria are important contaminants of food. Some of these bacteria are highly virulent pathogens, such as Clostridium botulinum and Clostridi m perfringens . Bacterial spores are difficult to eliminate because they are resistant to heating and many other sterilising treatments. They can be introduced at almost any stage during food manufacture in raw materials or as a result of careless handling, lack of hygiene or the like. Constant monitoring of raw materials, food production plants, factories or the like is therefore necessary to guard against gross contamination of food by these pathogens.
- the spoOA gene (or related homologs) is believed to occur in many Gram-positive endospore-forming bacteria such as Bacillus and Clostridium and to be absent from all non endospore- forming bacteria.
- the SpoOA protein product of the gene is a member of the response regulator super-family of ••two-component" signal transduction proteins.
- the SpoOA protein is an ambiactive transcription factor which is activated by phosphorylation to stimulate or repress expression of specific sets of target genes.
- the phosphorylated form of the SpoOA protein directly controls initiation of endospore formation and also influences, typically via an indirect mechanism, other stationary phase phenomena in endospore-forming organisms.
- the SpoOA protein has highly conserved regions within its carboxy and amino terminal domains, which domains are connected by a linker region, which region varies in sequence and length depending on the organism.
- deg ⁇ (or a related homolog) concerned with regulation of extracellular enzyme production in endospore-forming bacteria has also been found to have a conserved two-domain structure connected by a variable linker region. It has also been found that gene organisation in endospore-forming bacteria is substantially conserved. The highly conserved genes are connected by intergenic linker (non coding) regions of variable length, depending on the organism.
- a method of monitoring endospore-forming bacteria present in a sample comprises the steps of adding to the sample primers which are specific for conserved regions in a coding region in the genome of said bacteria, which coding region comprises two domains with a linker region connecting the two domains and which coding region is characteristic of an endospore-forming bacterium, carrying out a DNA amplification procedure so as to amplify conserved regions of the coding region present in said sample; and analysing for the conserved regions.
- DNA amplification technology it is possible by using DNA amplification technology to monitor the presence of endospore-forming bacteria which might be present in a given sample. The presence of DNA corresponding to the conserved regions is indicative of the presence of endospore-forming bacteria.
- the conserved regions comprise segments of the amino and carboxy terminal domains of a single gene, such as ⁇ poOA or deg ⁇ , the conserved regions being linked by the variable linker region.
- the conserved regions of the coding region comprise segments of separate adjacent genes such as spoIVB and spoOA whose disposition in the genome of the endospore-forming bacteria is highly conserved, and which genes are connected by a variable intergenic linker region.
- a method of identifying endospore-forming bacteria comprises the steps of adding primers to a sample containing endospore-forming bacteria, said primers being specific for the conserved regions of a coding region in the genome of the bacteria, which coding region is characteristic of an endospore-forming bacterium, carrying out a DNA amplification step so as to amplify conserved regions of the coding region and analysing the amplified DNA obtained, wherein said primers are such that they simultaneously amplify a DNA linker region of variable length connecting the conserved regions of the coding region, the length of the DNA fragment obtained from said amplification step being characteristic of a particular endospore-forming bacterium.
- endospore-forming bacteria which may be present in a given sample may be identified, based on the length of the variable DNA fragment connecting the conserved regions of the coding region, the linker region being amplified by the primers in addition to the conserved regions.
- the conserved regions of the coding region comprise segments of the amino and carboxy terminal domains of a single gene, such as spoOA or deg ⁇ , the conserved regions being separated by the variable linker region.
- the conserved regions comprise segments of separate adjacent genes whose disposition in the genome of the endospore-forming bacteria is highly conserved and which genes and their disposition in the genome are characteristic of a particular endospore-forming bacterium, the genes being connected by an intergenic non-coding region.
- the amplification step comprises the polymerase chain reaction, isothermal amplification or the like.
- the sample may be a clinical specimen, foodstuff or the like.
- a pair Of primers TIAARCCITTYGA and TAICCYTTIATRTGIGCIGGIACICC complementary to residues 107-111 (LKPFD) and 168-174 (PAHIKGY - reverse) of the deduced amino acid sequence of spoOA from B . subtilis were used to amplify DNA segments from several bacilli and clostridia using a Perkin Elmer GeneAmpTM PCR System 2400.
- Each reaction tube contained 100 pmole of each primer, 0.5 ⁇ g of target DNA, all four dNTPs at 200 ⁇ M each, 50mM KCI, 2mM MgCl 2 , lOmM Tris/HCl, 0.001% gelatin (Sigma), pH 8.0, and 2.5U of AmpliTaq DNA polymerase (Perkin Elmer Cetus) .
- After denaturation for 5 minutes at 94°C samples were amplified for 35 cycles comprising a 40 second denaturation period at 94°C, a 40 second annealing period at 40°C and a 40 second extension period at 72°C. Amplified products were analysed by electrophoresis through a 1.5% agarose gel. The results obtained are given in Table 1.
- Bacillus stearothermophilus 185 Bacillus stearothermophilus 185
- the DNA fragments were transferred by standard capillary blotting methods to a nylon membrane (Hybond N, Amersham) and hybridized under stringent conditions with 24-mer oligonucleotides (see below) that had been labelled at their 3' ends with digoxigenin, using a commercially available 3'-end labelling kit (Boehringer Mannheim) .
- the oligonucleotide specifically detected the PCR product derived from the organism from which the primer had been synthesized; none of the PCR products derived from any of the other organisms were detected.
- the sequences of the oligonucleotides employed in this experiment, together with the sequences of the corresponding region of the spoOA linker region, were as indicated in Table 2.
- a pair of primers ATIGARTGGATGYT and TAICCYTTIATRTGIGCIGGIACICC, complementary to residues 407-411 (IEWML) of ⁇ poIVB from B . subtilis and 168-174 (PAHIKGY - reverse) of spoOA from B . subtil is were used to amplify DNA segments from several bacilli and clostridia using a Perkin Elmer GeneAmpTMPCR System 2400.
- Each reaction tube contained 100 pmole of each primer, 0.5 ⁇ g of target DNA, all four dNTPs at 200 ⁇ M each, 50mM KCI, 2mM MgCl 2 , lOmM Tris/HCl, 0.01% gelatin (Sigma), pH 8.0, and 2.5 U of AmpliTaq DNA polymerase (Perkin Elmer Cetus). After denaturation for 5 min at 94°C samples were amplified for 35 cycles comprising a 40s denaturation period at 94°C, a 40s annealing period at 40°C and a 40s extension period at 72°C. Amplified products were analysed by electrophoresis through a 1.5% agarose gel. The results obtained are given in Table 3.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Endospore-forming bacteria present in a sample are detected or identified by adding to the sample primers which are specific for conserved regions in a coding region in the genome of the bacteria, and carrying out a DNA amplification procedure. In the detection method, any of the conserved regions present in the sample may be amplified, followed by analysing for the presence of the conserved regions. In the identification method, the conserved regions of the coding region are amplified, followed by analysing the amplified DNA obtained, the primers being such that they simultaneously amplify a variable coding sequence of DNA intermediate the conserved regions of the coding region, the length of the DNA fragment obtained from the amplification step being characteristic of a particular endospore-forming bacterium.
Description
Method of Monitoring Endospore-Forming Bacteria
The present invention relates to a method of monitoring endospore-forming bacteria.
Endospore-forming bacteria are important contaminants of food. Some of these bacteria are highly virulent pathogens, such as Clostridium botulinum and Clostridi m perfringens . Bacterial spores are difficult to eliminate because they are resistant to heating and many other sterilising treatments. They can be introduced at almost any stage during food manufacture in raw materials or as a result of careless handling, lack of hygiene or the like. Constant monitoring of raw materials, food production plants, factories or the like is therefore necessary to guard against gross contamination of food by these pathogens.
The spoOA gene (or related homologs) is believed to occur in many Gram-positive endospore-forming bacteria such as Bacillus and Clostridium and to be absent from all non endospore- forming bacteria. The SpoOA protein product of the gene is a member of the response regulator super-family of ••two-component" signal transduction proteins. The SpoOA protein is an ambiactive transcription factor which is activated by phosphorylation to stimulate or repress expression of specific sets of target genes. In particular, the phosphorylated form of the SpoOA protein directly controls initiation of endospore formation and also influences, typically via an indirect mechanism, other stationary phase phenomena in endospore-forming organisms.
The SpoOA protein has highly conserved regions within its carboxy and amino terminal domains, which domains are connected by a linker region, which region varies in sequence and length depending on the organism.
Likewise, another gene, degϋ (or a related homolog) concerned with regulation of extracellular enzyme production in endospore-forming bacteria has also been found to have a conserved two-domain structure connected by a variable linker region.
It has also been found that gene organisation in endospore-forming bacteria is substantially conserved. The highly conserved genes are connected by intergenic linker (non coding) regions of variable length, depending on the organism.
We have found that these conserved regions provide an effective marker for monitoring endospore-forming bacteria and that the variable linker regions separating the conserved regions provides highly specific markers for identifying individual species of endospore-forming bacteria.
Accordingly, there is provided by one aspect of the present invention, a method of monitoring endospore-forming bacteria present in a sample, which method comprises the steps of adding to the sample primers which are specific for conserved regions in a coding region in the genome of said bacteria, which coding region comprises two domains with a linker region connecting the two domains and which coding region is characteristic of an endospore-forming bacterium, carrying out a DNA amplification procedure so as to amplify conserved regions of the coding region present in said sample; and analysing for the conserved regions. Thus, advantageously, it is possible by using DNA amplification technology to monitor the presence of endospore-forming bacteria which might be present in a given sample. The presence of DNA corresponding to the conserved regions is indicative of the presence of endospore-forming bacteria.
In one embodiment of the invention, the conserved regions comprise segments of the amino and carboxy terminal domains of a single gene, such as εpoOA or degϋ, the conserved regions being linked by the variable linker region. In an alternative embodiment of the invention, the conserved regions of the coding region comprise segments of separate adjacent genes such as spoIVB and spoOA whose disposition in the genome of the endospore-forming bacteria is highly conserved, and which genes are connected by a variable intergenic linker region.
According to a second aspect of the present invention, there is provided a method of identifying endospore-forming bacteria, which method comprises the steps of adding primers to
a sample containing endospore-forming bacteria, said primers being specific for the conserved regions of a coding region in the genome of the bacteria, which coding region is characteristic of an endospore-forming bacterium, carrying out a DNA amplification step so as to amplify conserved regions of the coding region and analysing the amplified DNA obtained, wherein said primers are such that they simultaneously amplify a DNA linker region of variable length connecting the conserved regions of the coding region, the length of the DNA fragment obtained from said amplification step being characteristic of a particular endospore-forming bacterium.
Thus, advantageously, endospore-forming bacteria which may be present in a given sample may be identified, based on the length of the variable DNA fragment connecting the conserved regions of the coding region, the linker region being amplified by the primers in addition to the conserved regions.
In one embodiment, the conserved regions of the coding region comprise segments of the amino and carboxy terminal domains of a single gene, such as spoOA or degϋ, the conserved regions being separated by the variable linker region. Alternatively, the conserved regions comprise segments of separate adjacent genes whose disposition in the genome of the endospore-forming bacteria is highly conserved and which genes and their disposition in the genome are characteristic of a particular endospore-forming bacterium, the genes being connected by an intergenic non-coding region.
Preferably, the amplification step comprises the polymerase chain reaction, isothermal amplification or the like. Thus, very small numbers of organisms present in the sample may be identified. The sample may be a clinical specimen, foodstuff or the like.
The invention may be more clearly understood with reference to the following examples.
Example l
A pair Of primers TIAARCCITTYGA and TAICCYTTIATRTGIGCIGGIACICC complementary to residues 107-111 (LKPFD) and 168-174 (PAHIKGY - reverse) of the deduced amino acid sequence of spoOA from B . subtilis were used to amplify DNA segments from several bacilli and clostridia using a Perkin Elmer GeneAmp™ PCR System 2400. Each reaction tube contained 100 pmole of each primer, 0.5μg of target DNA, all four dNTPs at 200μM each, 50mM KCI, 2mM MgCl2, lOmM Tris/HCl, 0.001% gelatin (Sigma), pH 8.0, and 2.5U of AmpliTaq DNA polymerase (Perkin Elmer Cetus) . After denaturation for 5 minutes at 94°C samples were amplified for 35 cycles comprising a 40 second denaturation period at 94°C, a 40 second annealing period at 40°C and a 40 second extension period at 72°C. Amplified products were analysed by electrophoresis through a 1.5% agarose gel. The results obtained are given in Table 1.
Tab] Le l
Organism Approximate Size of Amplified DNA Fragment
Bacillus subtilis 205
Bacillus cereus 195
Bacillus stearothermophilus 185
Bacillus megateriu 190
Bacillus brevis 180
Clostridium beijerinckii 215
Clostridium butyricum 230
Clostridium pasteurianum 205
Clostridium thermoaceticum 170
Clostridium innocuum 205
Exam le 2
Three of the species listed in Table 1, viz Bacillus subtilis, Clostridium pasteurianum and Clostridium innocuu gave PCR products of indistinguishable size. They were differentiated by their ability to hybridize with oligonucleotides corresponding to unique segments of the variable linker region of spoOA.
The DNA fragments were transferred by standard capillary blotting methods to a nylon membrane (Hybond N, Amersham) and hybridized under stringent conditions with 24-mer oligonucleotides (see below) that had been labelled at their 3' ends with digoxigenin, using a commercially available 3'-end labelling kit (Boehringer Mannheim) . In each case, the oligonucleotide specifically detected the PCR product derived from the organism from which the primer had been synthesized; none of the PCR products derived from any of the other organisms were detected. The sequences of the oligonucleotides employed in this experiment, together with the sequences of the corresponding region of the spoOA linker region, were as indicated in Table 2.
Table 2 organism Peptide Oligonucleotide
B . subtilis NASSVTHR AATGCCAGGAGTGTGACGCATCGT
C. pasteurianum KAADVKIS AAAGCTGCAGATGTAAAGATTTCT
C. innocuum EHISSNVL GAGCATATATCCAGCAATGTGCTT
Example 3
Amplification of variable length products across the intergenic region separating spolΥB and spoOA.
A pair of primers ATIGARTGGATGYT and TAICCYTTIATRTGIGCIGGIACICC, complementary to residues 407-411 (IEWML) of εpoIVB from B . subtilis and 168-174 (PAHIKGY - reverse)
of spoOA from B . subtil is were used to amplify DNA segments from several bacilli and clostridia using a Perkin Elmer GeneAmp™PCR System 2400. Each reaction tube contained 100 pmole of each primer, 0.5μg of target DNA, all four dNTPs at 200μM each, 50mM KCI, 2mM MgCl2, lOmM Tris/HCl, 0.01% gelatin (Sigma), pH 8.0, and 2.5 U of AmpliTaq DNA polymerase (Perkin Elmer Cetus). After denaturation for 5 min at 94°C samples were amplified for 35 cycles comprising a 40s denaturation period at 94°C, a 40s annealing period at 40°C and a 40s extension period at 72°C. Amplified products were analysed by electrophoresis through a 1.5% agarose gel. The results obtained are given in Table 3.
Claims
1. A method of monitoring endospore-forming bacteria present in a sample, which method comprises the steps of adding to said sample primers which are specific for conserved regions in a coding region in the genome of said bacteria, which coding region comprising two domains with a linker region connecting the two domains, and which coding region is characteristic of an endospore-forming bacterium, carrying out a DNA amplification procedure so as to amplify conserved regions of the coding region present in said sample and analysing for the conserved regions.
2. A method according to claim 1, wherein said coding region comprises an individual gene, said conserved regions comprising the carboxy and amino terminal domains of said gene.
3. A method according to claim 2 wherein said gene comprises spoOA.
4. A method according to claim 1, wherein said coding region comprises segments of at least two adjacent genes, each of said genes coding for a distinguishable product.
5. A method according to claim 4, where said adjacent genes comprise spoTVB and spoOA.
6. A method of identifying endospore-forming bacteria which comprises the steps of adding primers to a sample containing endospore-forming bacteria, said primers being specific for the conserved regions of a coding region in the genome of said bacteria which coding region has a two- domain structure and is characteristic of an endospore- forming bacterium, carrying out a DNA amplification step so as to amplify conserved regions of the coding region and analysing the amplified DNA obtained, wherein said primers are such that they simultaneously amplify a DNA linker region of variable length connecting the conserved regions, the length of the DNA fragment obtained from said amplification step being characteristic of a particular endospore-forming bacterium.
7. A method according to claim 6, wherein said coding region comprises an individual gene, said conserved regions comprising the carboxy and amino terminal domains of said gene.
8. A method according to claim 7, wherein said gene comprises spoOA .
9. A method according to claim 6, wherein said coding region comprises segments of at least two separate adjacent genes coding for distinguishable products.
10 A method according to claim 9, wherein said adjacent genes comprise spoIVB and spoOA
11. A method according to any preceding claim wherein said amplification step comprises polymerase chain reaction amplification or isothermal amplification.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9420774 | 1994-10-14 | ||
GB9420774A GB9420774D0 (en) | 1994-10-14 | 1994-10-14 | Method of detecting and identifying spore forming bacteria |
GB9518661A GB2300481B (en) | 1994-10-14 | 1995-09-13 | Monitoring endospore-forming bacteria involving the amplification of DNA of conserved regions thereof |
GB9518661 | 1995-09-13 | ||
PCT/GB1995/002418 WO1996012038A1 (en) | 1994-10-14 | 1995-10-12 | Method of monitoring endospore-forming bacteria |
Publications (1)
Publication Number | Publication Date |
---|---|
EP0786013A1 true EP0786013A1 (en) | 1997-07-30 |
Family
ID=26305808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP95933543A Ceased EP0786013A1 (en) | 1994-10-14 | 1995-10-12 | Method of monitoring endospore-forming bacteria |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0786013A1 (en) |
AU (1) | AU3616395A (en) |
WO (1) | WO1996012038A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19801661A1 (en) * | 1998-01-17 | 1999-07-22 | Artus Ges Fuer Molekularbiolog | Rapid detection of organisms from analysis of ubiquitous nucleic acid sequences, e.g. for identifying pathogens |
US5928875A (en) * | 1998-05-27 | 1999-07-27 | Betzdearborn Inc. | Primers for the detection of spore forming bacteria |
CN1507496A (en) * | 2001-05-15 | 2004-06-23 | 赫尔克里士公司 | Detection of spore forming bacteria |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0502271A1 (en) * | 1989-04-17 | 1992-09-09 | The Standard Oil Company | 16s rRNA oligonucleotide probes for the identification of sulfate-reducing bacteria |
DE69032778T2 (en) * | 1989-07-18 | 1999-07-29 | Shimadzu Corp., Kyoto | Process for examining food poisoning caused by microorganisms and reagent therefor |
-
1995
- 1995-10-12 AU AU36163/95A patent/AU3616395A/en not_active Withdrawn
- 1995-10-12 WO PCT/GB1995/002418 patent/WO1996012038A1/en not_active Application Discontinuation
- 1995-10-12 EP EP95933543A patent/EP0786013A1/en not_active Ceased
Non-Patent Citations (1)
Title |
---|
See references of WO9612038A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO1996012038A1 (en) | 1996-04-25 |
AU3616395A (en) | 1996-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR19990008049A (en) | Universal targets for species identification | |
Cave et al. | Differentiation of Escherichia coli strains using randomly amplified polymorphic DNA analysis | |
JP3016399B2 (en) | Identification of Salmonella by polymerase chain reaction | |
WO2014173963A1 (en) | Strand-invasion based dna amplification method | |
US5948649A (en) | Method for identifying nucleic acid sequences from different biological sources through amplification of the same | |
US5922538A (en) | Genetic markers and methods for the detection of Listeria monocytogenes and Listeria spp | |
WO1996015264B1 (en) | Method for identifying nucleic acid sequences from different biological sources through amplification of the same | |
US20030235837A1 (en) | High resolution typing system for pathogenic E. coli | |
US20030113757A1 (en) | Rapid and specific detection of campylobacter | |
US6090551A (en) | Detection of bacteria of genus Listeria using nucleic probe hybridization techniques | |
Gray et al. | Polymerase chain reaction amplification of the flaA gene for the rapid identification of Listeria spp. | |
WO1996012038A1 (en) | Method of monitoring endospore-forming bacteria | |
US6074820A (en) | Detection and differentiation of mycobacterium tuberculosis complex bacteria by direct variant repeat oligotyping | |
US5869642A (en) | Detection of the genus pectinatus | |
CA2150986C (en) | Oligonucleotide primers and probes for detection of bacteria | |
Rudi et al. | Subtyping Listeria monocytogenes through the combined analyses of genotype and expression of the hlyA virulence determinant | |
JP4888622B2 (en) | Oligonucleotide and method for detecting batylscore glance using the same as primer | |
EP1602735B1 (en) | Method and kit for the detection and/or quantification of homologous nucleotide sequences on arrays | |
GB2300481A (en) | Monitoring endospore-forming bacteria by amplification of DNA of conserved regions | |
US5998138A (en) | Nucleotide sequence hybridizing specifically with a genomic nucleic sequence of campylobacter | |
WO2001068914A1 (en) | Nucleic acid primers of acid-fast bacterium and method of identifying acid-fast bacterium | |
Ferreira et al. | Detection of Clostridium botulinum type F using the polymerase chain reaction | |
Rudi et al. | Protocols for 16S rDNA array analyses of microbial communities by sequence‐specific labeling of DNA probes | |
CA2578401A1 (en) | Detection, identification of serratia species using 16s and 23s genes | |
Candrian et al. | Polymerase chain reaction with additional primers allows identification of amplified DNA and recognition of specific alleles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19970429 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): DE DK FR GB IE NL |
|
17Q | First examination report despatched |
Effective date: 19971110 |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20000518 |